D-dopa 110 : Levodopa USP 100 mg + Carbidopa USP 10 mg Tablet.
D-dopa is indicated for the treatment of idiopathic Parkinson's disease, post-encephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication or manganese intoxication.
D-dopa 110 : Levodopa USP 100 mg + Carbidopa USP 10 mg Tablet.
D-dopa is indicated for the treatment of idiopathic Parkinson's disease, post-encephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication or manganese intoxication.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.